Perelel's Latest Clinical Study Proves Efficacy Of Triple-Support Protein To Show Significant Benefits Across Metabolic and Cognitive Health in Women

Data ReadoutpositiveTriple-Support ProteinPositive

AI Analysis

Summary

Perelel announced positive results from a randomized, double-blind, placebo-controlled clinical study demonstrating that its Triple-Support Protein provides significant benefits for metabolic and cognitive health in women. The study adds to Perelel's clinical research portfolio in women's health.

Clinical Trial Data

Primary Endpoint

Met

Outcome Details

Randomized, double-blind, placebo-controlled study showed significant benefits across metabolic and cognitive health in women

Importance:5/10

Sentiment:

0.70

women's healthclinical trialmetabolic healthcognitive healthprotein supplement

Related Companies

$HIT

Read the original article

Published by PR Newswire Biotech on August 20, 2026 2:00 PM

Read Original